Abstract
Perioperative complications have been reported to be associated with a lower incidence of cancer-free survival. Perioperative atrial fibrillation (POAF) is one of occasionally observed complications in patients with malignancies who undergo noncardiac surgeries. However, the long-term clinical impact of POAF on those with malignancies have remained unknown. This was a prospective, single-center, observational study. Patients who underwent noncardiac surgeries for definitive malignancies between 2014 and 2017 were included. The primary and secondary endpoints were 3-year recurrence of malignancies and cancer death, respectively. The present study included consecutive 752 patients (mean age, 68 ± 11 years; males, 62%), and POAF was observed in 77 patients. The follow-up duration was 1037 (interquartile range, 699–1408) days. The 3-year recurrence of malignancies was observed in 239 (32%) patients (POAF, 32 [42%]; non-POAF, 207 [31%]) and 3-year mortality was 130 patients (17%). Cardiac, noncardiac, and cancer deaths were observed in 4 (0.5%), 126 (17%), and 111 (15%) patients, respectively. Multivariate Cox regression analysis demonstrated that POAF was associated with 3-year recurrence of malignancies (hazard ratio [HR], 1.70; 95% confidence interval [CI], 1.15–2.52). Landmark analysis demonstrated that POAF tended to be correlated with the incidence of 3-year cancer death (HR, 1.79; 95% CI, 0.96–3.31). In conclusion, POAF is associated with the subsequent recurrence of malignancies. The association of arrhythmia with cancer death may be revealed under longer follow-up durations.
Clinical Trial Registration: https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018270. UMIN ID: UMIN000016146.
Similar content being viewed by others
References
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Mokart D, Giaoui E, Barbier L, Lambert J, Sannini A, Chow-Chine L, Brun JP, Faucher M, Guiramand J, Ewald J, Bisbal M, Blache JL, Delpero JR, Leone M, Turrini O (2016) Postoperative sepsis in cancer patients undergoing major elective digestive surgery is associated with increased long-term mortality. J Crit Care 31(1):48–53
Wang S, Xu L, Wang Q, Li J, Bai B, Li Z, Wu X, Yu P, Li X, Yin J (2019) Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies. World J Surg Oncol 17(1):52
Higuchi S, Kabeya Y, Matsushita K, Arai N, Tachibana K, Tanaka R, Kawachi R, Takei H, Suzuki Y, Kogure M, Imanishi Y, Moriyama K, Yorozu T, Saito K, Abe N, Sugiyama M, Kondo H, Yoshino H (2019) Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy. PLoS ONE 14(5):e0216239
Friberg L, Rosenqvist M, Lip GY (2012) Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation 125(19):2298–2307
Andersson T, Magnuson A, Bryngelsson IL, Frøbert O, Henriksson KM, Edvardsson N, Poçi D (2013) All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case-control study. Eur Heart J 34(14):1061–1067
Jurin I, Lucijanic M, Jurin H, Starcevic B, Varvodic J, Catic J, Jurisic A, Vitlov P, Sokol Tomic S, Lucijanic J, Hadzibegovic I (2020) Patients with atrial fibrillation and mid-range ejection fraction differ in anticoagulation pattern, thrombotic and mortality risk independently of CHA(2)DS(2)-VAS(C) score. Heart Vessels 35(9):1243–1249
Gialdini G, Nearing K, Bhave PD, Bonuccelli U, Iadecola C, Healey JS, Kamel H (2014) Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 312(6):616–622
Butt JH, Olesen JB, Havers-Borgersen E, Gundlund A, Andersson C, Gislason GH, Torp-Pedersen C, Kober L, Fosbol EL (2018) Risk of thromboembolism associated with atrial fibrillation following noncardiac surgery. J Am Coll Cardiol 72(17):2027–2036
Higuchi S, Kabeya Y, Matsushita K, Arai N, Tachibana K, Tanaka R, Kawachi R, Takei H, Suzuki Y, Kogure M, Imanishi Y, Moriyama K, Sugiyama M, Yorozu T, Saito K, Abe N, Kondo H, Yoshino H (2019) Perioperative atrial fibrillation in noncardiac surgeries for malignancies and one-year recurrence. Can J Cardiol 35(11):1449–1456
Aguilar M, Nattel S (2019) Postoperative atrial fibrillation after noncardiac surgery: maybe not so benign after all. Can J Cardiol 35(11):1423–1425
Vinter N, Christesen AMS, Fenger-Grøn M, Tjønneland A, Frost L (2018) Atrial fibrillation and risk of cancer: a Danish population-based cohort study. J Am Heart Assoc 7(17):e009543
Kamp DW, Shacter E, Weitzman SA (2011) Chronic inflammation and cancer: the role of the mitochondria. Oncology (Williston Park) 25(5):400–410
Wu R, Fang J, Liu M, Jun A, Liu J, Chen W, Li J, Ma G, Zhang Z, Zhang B, Fu L, Dong JT (2020) SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation. J Biol Chem 295(19):6741–6753
Conen D, Wong JA, Sandhu RK, Cook NR, Lee IM, Buring JE, Albert CM (2016) Risk of malignant cancer among women with new-onset atrial fibrillation. JAMA Cardiol 1(4):389–396
Hung YP, Hu YW, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, Chen SA, Albert CM, Chao TF (2019) Risk and predictors of subsequent cancers of patients with newly-diagnosed atrial fibrillation—a nationwide population-based study. Int J Cardiol 296:81–86
Higuchi S, Kabeya Y, Matsushita K, Tachibana K, Kawachi R, Takei H, Suzuki Y, Abe N, Imanishi Y, Moriyama K, Yorozu T, Saito K, Sugiyama M, Kondo H, Yoshino H (2018) The study protocol for PREDICT AF RECURRENCE: a PRospEctive cohort stuDy of surveIllanCe for perioperaTive Atrial Fibrillation RECURRENCE in major non-cardiac surgery for malignancy. BMC Cardiovasc Disord 18(1):127
Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M (2013) Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol 20(5):1575–1583
Climent M, Hidalgo N, Vidal Ó, Puig S, Iglesias M, Cuatrecasas M, Ramón JM, García-Albéniz X, Grande L, Pera M (2016) Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. Eur J Surg Oncol 42(1):132–139
Watanabe M, Kinoshita T, Tokunaga M, Kaito A, Sugita S (2018) Complications and their correlation with prognosis in patients undergoing total gastrectomy with splenectomy for treatment of proximal advanced gastric cancer. Eur J Surg Oncol 44(8):1181–1185
Ostenfeld EB, Erichsen R, Pedersen L, Farkas DK, Weiss NS, Sørensen HT (2014) Atrial fibrillation as a marker of occult cancer. PLoS ONE 9(8):e102861
Rudolph V, Andrié RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K, Sydow K, Didié M, Seniuk A, von Leitner EC, Szoecs K, Schrickel JW, Treede H, Wenzel U, Lewalter T, Nickenig G, Zimmermann WH, Meinertz T, Böger RH, Reichenspurner H, Freeman BA, Eschenhagen T, Ehmke H, Hazen SL, Willems S, Baldus S (2010) Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16(4):470–474
Chandel NS, Tuveson DA (2014) The promise and perils of antioxidants for cancer patients. N Engl J Med 371(2):177–178
Zhang YL, Cao HJ, Han X, Teng F, Chen C, Yang J, Yan X, Li PB, Liu Y, Xia YL, Guo SB, Li HH (2020) Chemokine receptor CXCR-2 initiates atrial fibrillation by triggering monocyte mobilization in mice. Hypertension 76(2):381–392
White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ (2014) Age and cancer risk: a potentially modifiable relationship. Am J Prev Med 46(3 Suppl 1):S7-15
Friberg L, Benson L, Rosenqvist M, Lip GY (2012) Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 344:e3522
Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364(9):829–841
Maixent JM, Paganelli F, Scaglione J, Lévy S (1998) Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 9(6):612–617
Su VY, Hu YW, Chou KT, Ou SM, Lee YC, Lin EY, Chen TJ, Tzeng CH, Liu CJ (2013) Amiodarone and the risk of cancer: a nationwide population-based study. Cancer 119(9):1699–1705
Andersson P, Frigyesi A (2019) High-sensitivity troponin T is an important independent predictor in addition to the Simplified Acute Physiology Score for short-term ICU mortality, particularly in patients with sepsis. J Crit Care 53:218–222
Putot A, Derrida SB, Zeller M, Avondo A, Ray P, Manckoundia P, Cottin Y (2018) Short-term prognosis of myocardial injury, type 1, and type 2 myocardial infarction in the emergency unit. Am J Med 131(10):1209–1219
Long B, Long DA, Tannenbaum L, Koyfman A (2020) An emergency medicine approach to troponin elevation due to causes other than occlusion myocardial infarction. Am J Emerg Med 38(5):998–1006
Higuchi S, Suzuki M, Horiuchi Y, Tanaka H, Saji M, Yoshino H, Nagao K, Yamamoto T, Takayama M (2019) Higher non-cardiac mortality and lesser impact of early revascularization in patients with type 2 compared to type 1 acute myocardial infarction: results from the Tokyo CCU Network registry. Heart Vessels 34(7):1140–1147
Putot A, Chagué F, Manckoundia P, Brunel P, Beer JC, Cottin Y, Zeller M (2020) Post-infectious myocardial infarction: does percutaneous coronary intervention improve outcomes? A Propensity Score-matched analysis. J Clin Med 9(6):1608
Huang J, Wu N, Xiang Y, Wu L, Li C, Yuan Z, Jia X, Zhang Z, Zhong L, Li Y (2020) Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation. Int J Cardiol 320:83–89
Anzai T (2018) Inflammatory mechanisms of cardiovascular remodeling. Circ J 82(3):629–635
Kim SH, Jang MJ, Hwang HY (2020) Perioperative beta-blocker for atrial fibrillation after cardiac surgery: a meta-analysis. Thorac Cardiovasc Surg 69(2):133–140
AlTurki A, Marafi M, Proietti R, Cardinale D, Blackwell R, Dorian P, Bessissow A, Vieira L, Greiss I, Essebag V, Healey JS, Huynh T (2020) Major adverse cardiovascular events associated with postoperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 13(1):e007437
Funding
This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant Number 17K18085 (S.H.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Higuchi has received lecture fees from Medtronic Japan Co., Ltd., Daiichi Sankyo Co., Ltd., and Ono Pharmaceutical Co., Ltd. The remaining authors have no disclosures to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Higuchi, S., Kabeya, Y., Matsushita, K. et al. Clinical impact of perioperative atrial fibrillation on long-term recurrence of malignancy. Heart Vessels 37, 619–627 (2022). https://doi.org/10.1007/s00380-021-01954-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-021-01954-4